11-aminoazonafide | 140937-12-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 英文名称: 11-aminoazonafide
• 英文别名: 11-amino-2-[2-(dimethylamino)ethyl]-1H-dibenzo[de,h]isoquinoline-1,3(2H)-dione；3-amino-15-[2-(dimethylamino)ethyl]-15-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(17),2(7),3,5,8,10,12-heptaene-14,16-dione
• CAS: 140937-12-8
• 化学式: C₂₀H₁₉N₃O₂
• 分子量: 333.39
• InChiKey: KJDQEAYPSNOTSK-UHFFFAOYSA-N

物化性质

• 沸点：
  565.4±35.0 °C(Predicted)
• 密度：
  1.328±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  66.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  11-aminoazonafide 在 盐酸 、 sodium nitrite 作用下， 以60%的产率得到15-[2-(Dimethylamino)ethyl]-3-hydroxy-15-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(17),2(7),3,5,8,10,12-heptaene-14,16-dione
  参考文献：
  名称：

  2- [2'-（二甲氨基）乙基] -1，2-二氢-3H-二苯并[de，h]异喹啉-1,3-二酮，在4、8、9、10和11位具有取代基。抗肿瘤活性和定量构效关系。

  摘要：

  新的2- [2'-（二甲基氨基）乙基] -1,2-二氢-3H-二苯并[de，h]异喹啉-1,3-二酮在4、8、9、10和11位带有取代基合成的。由氨基氮杂胺制备的重氮盐是许多类似物的关键中间体。在包括人类黑素瘤和卵巢癌以及鼠L1210白血病在内的一系列肿瘤细胞中，六种新化合物比阿扎那非更有效。这些化合物中的三种，即10-OCH3、10-OC2H5和10-F类似物，其心脏毒性与肿瘤细胞毒性的比率比阿扎那非好。八种化合物对MDR L1210白血病没有交叉耐药性，而且10-CN类似物对实体瘤细胞的作用比对白血病细胞的作用更强。9-OH，10-CN，和10-F类似物对MFX 7乳腺癌和WiDr结肠癌以及敏感性A599肺癌的敏感和耐药细胞系均具有高效力。在小鼠的P388白血病中，10-Cl，10-NH2和10-CN类似物优于阿扎那非的优势是显而易见的，在这种测定中，10-CN类似物比阿霉素更有效。定

  DOI：

  10.1021/jm960623g
• 作为产物：
  描述：

  2-[2-(dimethylamino)ethyl]-11-nitro-1H-dibenzo[de,h]isoquinoline-1,3(2H)-dione 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 反应 5.0h， 以62%的产率得到11-aminoazonafide
  参考文献：
  名称：

  Amino-Substituted 2-[2-(Dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. Synthesis, Antitumor Activity, and Quantitative Structure-Activity Relationship

  摘要：

  Sets of 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones with amino and actylamino groups at each of the eight positions on the anthracene nucleus were synthesized from appropriately substituted anthracenes. Their evaluation in in vitro antitumor and cardiotoxicity assays revealed a very strong dependence of potency on the position of substitution. Certain compounds, including the 4-, 5-, 7-, and 9-amino derivatives, showed significantly higher potency than the unsubstituted parent compound, azonafide. Among them, 7-aminoazonafide had low cardiotoxicity relative to cytotoxicity. In general, the acetylamino analogues were less potent than the amino derivatives against tumor cells and neonatal rat heart myocytes; however, 5-(acetylamino)azonafide was highly cardiotoxic. 9-Aminoazonafide was more efficacious than azonafide or amonafide against P388 leukemia in mice. Statistically significant correlations were made between the ability of amino analogues to increase the transition melt temperature (Delta T-m) of DNA and their potency against solid tumors, leukemia cells, or cardiac myocytes.

  DOI：

  10.1021/jm00006a018

文献信息

• Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
  申请人：Unibioscreen S.A.

  公开号：EP1787985A1

  公开（公告）日：2007-05-23

  Azonafide derivatives are obtained by reacting azonafide with aldehydes, acyl halides, thioacyl halides, monoisocyanates, isothiocyanates or polyamines, and are useful as active ingredients of pharmaceutical compositions for the treament of cell proliferative disorders.

  Azonafide衍生物是通过将azonafide与醛类、酰卤、硫酰卤、单异氰酸酯、异硫氰酸酯或多胺反应而得到的，它们可作为药物组合物的有效成分，用于治疗细胞增殖性疾病。
• Azonafide Derivatives, Methods for Their Production and Pharmaceutical Compositions Therefrom
  申请人：Van Quaquebeke Eric

  公开号：US20080292585A1

  公开（公告）日：2008-11-27

  Azonafide derivatives are obtained by reacting azonafide with aldehydes, acyl halides, thioacyl halides, monoisocyanates, isothiocyanates, sulfonyl halides, monohalogenoalkanes, monohalogenoalkenes or monohalogenoalkynes, and are useful as active ingredients of pharmaceutical compositions for the prevention and treatment of cell proliferative disorders, in particular several forms of Cancer.

  Azonafide衍生物是通过将azonafide与醛类、酰卤、硫酰卤、单异氰酸酯、异硫氰酸酯、磺酰卤、单卤代烷烃、单卤代烯烃或单卤代炔烃反应得到的，并且它们可用作制药组合物的活性成分，用于预防和治疗细胞增殖性疾病，特别是几种癌症。
• AZONAFIDE DERIVATIVES, METHODS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THEREFROM
  申请人：Unibioscreen S.A.

  公开号：EP1960365A2

  公开（公告）日：2008-08-27
• COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED NAPHTHALIMIDES SUCH AS AMONAFIDE FOR THE TREATMENT OF IMMUNOLOGICAL, METABOLIC, INFECTIOUS, AND BENIGN OR NEOPLASTIC HYPERPROLIFERATIVE DISEASE CONDITIONS
  申请人：BROWN Dennis M.

  公开号：US20160067241A1

  公开（公告）日：2016-03-10

  The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to naphthalimides such as amonafide or analogs, derivatives, or prodrugs thereof.
• US7741337B2
  申请人：——

  公开号：US7741337B2

  公开（公告）日：2010-06-22